The NHLBI announces a grant opportunity to conduct essential pilot studies that inform the design of clinical trials related to heart, lung, blood, and sleep disorders. This grant aims to assess novel trial designs and intervention feasibility to facilitate subsequent clinical trial planning. Applications must demonstrate the necessity and sufficiency of the proposed studies. Projects focused solely on protocol development will not be considered. The NHLBI expects the R34 award to generate strong clinical trial grant applications for interventions targeting heart, lung, blood, and sleep disorders. Closing date for applications is Jan 07, 2021.
Opportunity ID: 299186
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-463 |
Funding Opportunity Title: | NHLBI Clinical Trial Pilot Studies (R34 – Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 01, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 07, 2021 |
Current Closing Date for Applications: | Jan 07, 2021 |
Archive Date: | Feb 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $225,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Small businesses City or township governments Special district governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is to support studies that are essential, yet also sufficient, for investigators to make definitive decisions about the designs of important clinical trials within NHLBI’s mission, the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed pilot studies are both necessary and sufficient to permit definitive decisions about the design of the subsequent clinical trial. Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for this announcement. The NHLBI anticipates that the R34 award period will yield robust investigator-initiated clinical trial grant applications for the evaluation of interventions for the treatment or prevention of heart, lung, blood, or sleep disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-463.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00236709 | Jan 16, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260087 | Jan 16, 2018 | Jan 07, 2021 | View |
Package 1
Mandatory forms
299186 RR_SF424_2_0-2.0.pdf
299186 PHS398_CoverPageSupplement_4_0-4.0.pdf
299186 RR_OtherProjectInfo_1_4-1.4.pdf
299186 PerformanceSite_2_0-2.0.pdf
299186 RR_KeyPersonExpanded_2_0-2.0.pdf
299186 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299186 RR_Budget_1_4-1.4.pdf
299186 RR_SubawardBudget30_1_4-1.4.pdf
299186 PHS398_ModularBudget_1_2-1.2.pdf
299186 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299186 RR_SF424_2_0-2.0.pdf
299186 PHS398_CoverPageSupplement_5_0-5.0.pdf
299186 RR_OtherProjectInfo_1_4-1.4.pdf
299186 PerformanceSite_2_0-2.0.pdf
299186 RR_KeyPersonExpanded_2_0-2.0.pdf
299186 PHS398_ResearchPlan_4_0-4.0.pdf
299186 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299186 RR_Budget_1_4-1.4.pdf
299186 RR_SubawardBudget30_1_4-1.4.pdf
299186 PHS398_ModularBudget_1_2-1.2.pdf
299186 PHS_AssignmentRequestForm_3_0-3.0.pdf